The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Information source: Yeungnam University College of Medicine
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Central Serous Chorioretinopathy
Intervention: Photodynamic therapy (Procedure)
Phase: N/A
Status: Recruiting
Sponsored by: Yeungnam University College of Medicine Overall contact: Min Sagong, Phone: 82-53-620-4191, Email: msagong@ynu.ac.kr
Summary
To find the safe effective lowest light dose for photodynamic therapy (PDT). in the
treatment of central serous chorioretinopathy.
Clinical Details
Official title: The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: Changes of best corrected visual acuity
Secondary outcome: Change of central retinal thickness, success rate, recurrence rate, and complications
Eligibility
Minimum age: 20 Years.
Maximum age: 70 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
1. Idiopathic detachment of the neurosensory retina with a focal leak at the level of
the RPE with FA
2. Presence of SRF and/or serous pigment epithelial detachment on optical coherence
tomography (OCT)
3. Presence of abnormal dilated choroidal vasculature in ICGA
4. Patients with symptomatic CSC of at least 3 months duration
Exclusion Criteria:
1. Patients who received any previous treatment, including PDT or focal thermal laser
photocoagulation for CSC, or who had evidence of CNV, PCV, or other maculopathy on
clinical examination, FA, or ICGA
2. Patients receiving exogenous corticosteroid treatment
3. Patients with systemic diseases such as Cushing's disease or renal diseases
4. Pregnant patients
Locations and Contacts
Min Sagong, Phone: 82-53-620-4191, Email: msagong@ynu.ac.kr
Yeungnam University College of Medicine, Daegu, Korea, Republic of; Recruiting Min Sagong, Phone: 82-53-620-4191, Email: msagong@ynu.ac.kr Min Sagong, Principal Investigator
Additional Information
Starting date: June 2012
Last updated: February 13, 2015
|